Stormi E. Gale

ORCID: 0000-0003-2533-3373
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Heart Failure Treatment and Management
  • Renal Transplantation Outcomes and Treatments
  • Erythropoietin and Anemia Treatment
  • Iron Metabolism and Disorders
  • Transplantation: Methods and Outcomes
  • Pulmonary Hypertension Research and Treatments
  • Pharmaceutical Economics and Policy
  • Potassium and Related Disorders
  • Blood Pressure and Hypertension Studies
  • Polyomavirus and related diseases
  • HIV/AIDS drug development and treatment
  • Diabetes Treatment and Management
  • Medication Adherence and Compliance
  • Cardiac pacing and defibrillation studies
  • Cardiovascular Function and Risk Factors
  • Medical Education and Admissions
  • Lipoproteins and Cardiovascular Health
  • Personality Traits and Psychology
  • Diabetes Management and Research
  • Hemoglobinopathies and Related Disorders
  • Health Systems, Economic Evaluations, Quality of Life
  • Hormonal and reproductive studies
  • Acute Kidney Injury Research
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Pharmaceutical industry and healthcare

Novant Health
2022-2025

Carolinas Medical Center
2024

University of Maryland, Baltimore
2018-2022

The University of Texas Health Science Center at San Antonio
2021

University of Utah
2021

University of Maryland, College Park
2021

University of Maryland Medical Center
2018

Wingate University
2015

Managed care payers, pharmacy directors, benefit managers, specialty and any other pharmacist and/or healthcare professional interested in scientific advances pulmonary arterial hypertension Activity OverviewPulmonary (PAH) is a rare, progressive disorder with currently unknown etiology.Initial symptoms are often nonspecific include shortness of breath fatigue, some patients experiencing these for more than 2 years before receiving diagnosis.As PAH progresses, may become severe occur at...

10.37765/ajmc.2021.88611 article EN The American Journal of Managed Care 2021-03-01

The use of alemtuzumab for induction therapy in orthotopic heart transplantation remains controversial, despite its observed benefits other transplant populations. This study aimed to evaluate whether conferred a lower risk rejection while reducing toxicities commonly attributed standard immunosuppression transplantation. We included adult patients who underwent and received with (n = 26) or 26). primary end point was freedom from grade ≥2 at 12 months. Baseline characteristics were similar...

10.1177/1074248419841635 article EN Journal of Cardiovascular Pharmacology and Therapeutics 2019-04-29

Sensitization remains a barrier to heart transplantation (HT). Perioperative desensitization strategies have been described; however, paucity of evidence exists demonstrate efficacy and safety in HT.This single-center, retrospective study consisted adults who received an HT. was initiated if virtual crossmatch or flow-cytometry positive. Therapy plasmapheresis, intravenous immunoglobulin, rabbit antithymocyte globulin. Historical controls standard immunosuppression induction. The primary...

10.1097/txd.0000000000001111 article EN cc-by-nc-nd Transplantation Direct 2021-01-26

Patients living with HIV (PLWH) are predisposed to atherosclerotic cardiovascular disease (ASCVD), resulting in concomitant antiretroviral and statin use. A prescribing gap for PLWH has been reported, but appropriateness of selection dosing (ASD) not described.This is a comparative, retrospective study reviewing ASD vs. uninfected patients at two outpatient clinics within an academic medical centre. Adults > 21 years old indicated therapy were included. The primary outcome was percentage...

10.1111/hiv.13150 article EN HIV Medicine 2021-08-08

To help ensure that we were accurately and consistently evaluating applicants to our postgraduate year 1 (PGY1) pharmacy residency program, performed a job analysis inform redesign of selection process.A diverse panel subject matter experts from program was convened develop task inventory; list knowledge, skills, abilities, other characteristics necessary for success in program; behavioral snapshots representing especially strong or weak resident performance (ie, critical incidents). After...

10.1093/ajhp/zxac119 article EN American Journal of Health-System Pharmacy 2022-05-03

This study assessed whether personality testing of postgraduate year 1 (PGY1) pharmacy residency applicants was feasible and predicted important selection outcomes, including interview offers.Applicants to the PGY1 program at a large academic medical center were invited complete 50-item online test based on 5-factor model (ie, "Big Five"). Scores sealed until after matching, which point they compared screening, interview, ranking match outcomes. Endpoints interest included feasibility (eg,...

10.1093/ajhp/zxab450 article EN American Journal of Health-System Pharmacy 2021-11-27
Coming Soon ...